EquityFlow
›
Companies
› Cinclus Pharma
Cinclus Pharma
Biotech
· Stockholm, SE ·
cincluspharma.com
Late-stage biopharma developing a treatment for GERD
Funding history
Date
Round
Amount
May 2022
Funding round
Stockholm biotech Cinclus Pharma raised about EUR22M in a private placement led by Trill Impact to accelerate commercialisation.
$23.3M
Investors
Eir Ventures
Linc
Trill Impact
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →